Novartis AG (NVS) Stock: Revenue, Earnings, Margins & Valuation
Novartis AG (NVS), Switzerland at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Novartis AG key figures (FY 2025)
| Revenue | 54.53 USD bn |
|---|---|
| Gross profit | 47.93 USD bn |
| Operating income | 17.63 USD bn |
| Net income | 13.98 USD bn |
| Net margin | 25.6 % |
Novartis AG revenue by segment
| United States | 23.33 USD bn |
|---|---|
| Europe | 16.73 USD bn |
| Asia/Africa/Australasia | 10.80 USD bn |
| Canada and Latin America | 3.67 USD bn |
Novartis AG business model
The income statement of Novartis AG is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.
More stock analyses like Novartis AG
- Roche Holding AG stock (RHHBY)
- NextEra Energy Inc. stock (NEE)
- Novo Nordisk A/S stock (NVO)
- Netflix Inc. stock (NFLX)
- NVIDIA Corporation stock (NVDA)
- Nestlé S.A. stock (NESN.SW)
- Oracle Corporation stock (ORCL)
- Morgan Stanley stock (MS)
- Palantir Technologies stock (PLTR)
- Mitsubishi UFJ Financial Group stock (MUFG)